We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 121-140 of 3,759 results
  1. Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities

    Antibody drug conjugates (ADCs) are promising cancer therapeutics with minimal toxicity as compared to small cytotoxic molecules alone and have shown...

    Ritwik Maiti, Bhumika Patel, ... Nirav Dhanesha in Archives of Pharmacal Research
    Article 18 April 2023
  2. (–)-cleistenolide and its Analogs as New Potential Antitumor Compounds Against PC-3 Cells

    In order to find and develop new active compounds against prostate cancer, (–)-cleistenolide ( 1 ) and its 24 new analogs were evaluated for in vitro ...

    Vladimir R. Vukic, Dajana V. Vukic, ... Velimir Popsavin in Pharmaceutical Chemistry Journal
    Article 17 August 2022
  3. Antioxidant and Anti-Inflammatory Activities of Dihydroquercetin, its Aminomethylated Derivative, and their Inclusion Complexes with Cyclodextrin

    The antioxidant properties of dihydroquercetin (DHQ, taxifolin), its aminomethylated derivative (KH-14), and their inclusion complexes in...

    V. S. Rogovskii, A. I. Matyushin, ... N. L. Shimanovsky in Pharmaceutical Chemistry Journal
    Article 18 November 2021
  4. L-proline transporter inhibitor (LQFM215) promotes neuroprotection in ischemic stroke

    Background

    L-proline transporter (PROT/SLC6A7) is closely associated with glutamatergic neurotransmission, where L-proline modulates the NMDA receptor...

    Gustavo Almeida Carvalho, Raphaela Almeida Chiareli, ... Mauro Cunha Xavier Pinto in Pharmacological Reports
    Article 31 January 2023
  5. Nano-Nutraceuticals for Health: Principles and Applications

    The use of nanotechnological products is increasing steadily. In this scenario, the application of nanotechnology in food science and as a...

    Tais Monteiro Magne, Luciana Magalhães Rebelo Alencar, ... Ralph Santos-Oliveira in Revista Brasileira de Farmacognosia
    Article 23 November 2022
  6. Kinetics of Omeprazole Release from Enteric Dosage Forms of Different Manufacturers

    A comparative dissolution kinetics test (CDKT) related to proton-pump inhibitors (PPIs), particularly omeprazole, using dissolution media with pH 1.2...

    S. Yu. Serebrova, D. O. Kurguzova, ... A. B. Prokofiev in Pharmaceutical Chemistry Journal
    Article 01 January 2024
  7. Common Deficiencies Found in the Active Pharmaceutical Ingredient (API) Section of Non-sterile Generic Products Submitted for Registration by SAHPRA

    Purpose

    This research study aims to determine the qualitative and quantitative common deficiencies included in the API section of dossiers submitted...

    Lerato Moeti, Madira Litedu, Jacques Joubert in Therapeutic Innovation & Regulatory Science
    Article 02 December 2021
  8. Synthesis and Biological Activity of 4-(3,4-Dibromothiophenecarbonyl)-2,6,8,10,12-Pentaacetyl-2,4,6,8,10,12-Hexaazaisowurtzitane: A New Non-Narcotic Analgesic of the Hexaazaisowurtzitane Class

    A method for production of a promising non-narcotic analgesic of the hexaazaisowurtzitane class is developed. Data on the physicochemical...

    V. V. Eremina, D. A. Kulagina, ... V. V. Zhdanov in Pharmaceutical Chemistry Journal
    Article 13 April 2023
  9. Change in Chromatographic Parameters of Some Phenylpropanoids in Different Mobile Phases Under Reversed-Phase HPLC Conditions

    The effect of the eluent composition (type and concentration of the organic and acid components) on the retention times and selectivity of the...

    O. K. Abramov, A. F. Ryabukha, I. V. Pletneva in Pharmaceutical Chemistry Journal
    Article 01 April 2024
  10. Vortioxetine liposomes as a novel alternative to improve drug stability under stress conditions: toxicity studies and evaluation of antidepressant-like effect

    Background

    Vortioxetine hydrobromide (VXT), a new therapeutic option in the treatment of major depressive disorder, is a poorly soluble drug, and...

    Caroline Hermann Nodari, Natália Dalanhol De Quadros, ... Simone Gasparin Verza in Pharmacological Reports
    Article 09 September 2022
  11. Evaluation of epithelial transport and oxidative stress protection of nanoengineered curcumin derivative-cyclodextrin formulation for ocular delivery

    Ocular drug delivery has been a well-known route for the drug administration for the treatment of ocular diseases. However, numerous anatomical and...

    Pooja Maharjan, Minki **, ... Kyoung Ah Min in Archives of Pharmacal Research
    Article 27 April 2019
  12. Molecular mechanism of ferulic acid and its derivatives in tumor progression

    Cancer is a significant disease that poses a major threat to human health. The main therapeutic methods for cancer include traditional surgery,...

    **ngxun Bao, Wei Li, ... Lei **a in Pharmacological Reports
    Article Open access 18 May 2023
  13. Studies of the Possibility of Using Renal Biomarkers to Assess Drug Nephrotoxicity in an RPTEC/TERT1 Cell Line Model

    We report here studies of the possibility of using contemporary biomarkers of in vivo kidney damage - cystatin C and clusterin – in the RPTEC/TERT1...

    V. A. Evteev, I. S. Semenova, ... A. B. Prokof’ev in Pharmaceutical Chemistry Journal
    Article 01 October 2023
  14. Inclusion Complex of 11-deoxymisoprostol and Glycyrrhizic Acid with Improved Anti-Ulcer Activity

    A 1:4 inclusion complex of 11-deoxymisoprostol ( II ) with glycyrrhizic acid (complex III ) was synthesized and exhibited high anti-ulcer activity in...

    L. A. Baltina, N. A. Ivanova, ... M. S. Miftakhov in Pharmaceutical Chemistry Journal
    Article 16 August 2022
  15. QUALITY REQUIREMENTS FOR HERBAL DRUGS; ANALYTICAL METHODS

    In the broadest sense, all plants that are used for healing purposes, based on either traditional use or scientific data, are referred to as...
    Éva Szöke, Ágnes Kéry, Éva Lemberkovics in From Herbs to Healing
    Chapter 2023
  16. PBPK modeling to predict the pharmacokinetics of venlafaxine and its active metabolite in different CYP2D6 genotypes and drug–drug interactions with clarithromycin and paroxetine

    Venlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI), is indicated for the treatment of major depressive disorder, social anxiety...

    Chang-Keun Cho, Pureum Kang, ... Chang-Ik Choi in Archives of Pharmacal Research
    Article 25 April 2024
  17. The Prospects of 5-Androstenediol and its Synthetic Derivatives as Novel Radioprotective Drugs

    The steroid hormone 5-androstenediol (5-AED) has been advanced as a possible countermeasure for protection from ionizing radiation. It is highly...

    M. E. Uspenskaya, T. A. Fedotcheva, ... N. L. Shimanovsky in Pharmaceutical Chemistry Journal
    Article 01 March 2024
  18. Glycoalkaloids of Plants in the Family Solanaceae (Nightshade) as Potential Drugs

    Worldwide interest in medicinal plants and related drugs is growing because of the increased spectrum of new synthetic drugs. In this context,...

    T. O. Ostreikova, O. V. Kalinkina, ... I. V. Chernykh in Pharmaceutical Chemistry Journal
    Article 18 October 2022
  19. Development of a Quantitative Determination Technique for Ascorbic Acid in Medicines

    A coordination compound of iron(III) ion with 1,10-phenanthroline, or the oxidized form of ferroin (OFF), which was obtained via the reaction of...

    N. Sh. Kaisheva, A. Sh. Kaishev in Pharmaceutical Chemistry Journal
    Article 01 December 2023
  20. Be aware of the risks of nephrotoxicity when prescribing amoxicillin and third-generation cephalosporins

    Amoxicillin and third-generation cephalosporins are widely used in the prevention and treatment of established infections. These broad-spectrum...

    Amy Zhuang-Yan in Drugs & Therapy Perspectives
    Article 21 March 2024
Did you find what you were looking for? Share feedback.